XFOR 8-K 2026-07-01

X4 Pharmaceuticals, Inc (XFOR) 8-K dated 2026-07-01 — accession 0001501697-26-000060. This URL is the filing, not the XFOR hub.

X4 Pharmaceuticals, Inc (XFOR) is a biotechnology company listed on NASDAQ.

X4 Pharmaceuticals, Inc filed a 8-K on 2026-07-01. Accession 0001501697-26-000060.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.

Not investment advice. The XFOR SEC hub lists recent forms. The stock page is the research view.